BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Dec 5, 2025; 16(4): 110642
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.110642
Figure 1
Figure 1 Patient flowchart and patient disposition. 1Two patients did not reach the administrative 24-week assessment because of late enrollment.

  • Citation: Solar Muñiz H, Fernández A, Busoni V, Martínez MI, Rumbo C, De Barrio S, Saure C, Balacco M, Buncuga MG, Dlugoszweski C, Manzur A, Rudi L, Matoso MD, Cosentino S, Ussher F, Manzur F, Demarchi J, Malaver E, Brion L, Ungar L. Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina. World J Gastrointest Pharmacol Ther 2025; 16(4): 110642
  • URL: https://www.wjgnet.com/2150-5349/full/v16/i4/110642.htm
  • DOI: https://dx.doi.org/10.4292/wjgpt.v16.i4.110642

Write to the Help Desk